Publicaciones en las que colabora con José Luis González Larriba (9)

2021

  1. LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

    Cancer Medicine, Vol. 10, Núm. 17, pp. 5878-5888

2020

  1. Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study

    BMC Psychology, Vol. 8, Núm. 1

2019

  1. Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

    Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132

2017

  1. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non–Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery

    Clinical Lung Cancer, Vol. 18, Núm. 2, pp. 178-188.e4

  2. Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

    Clinical and Translational Oncology, Vol. 19, Núm. 2, pp. 219-226

2016

  1. Lung cancer in women with a family history of cancer: The Spanish female-specific database WORLD07

    Anticancer Research, Vol. 36, Núm. 12, pp. 6647-6653

2011

  1. Management of lung cancer-associated anaemia: The Spanish Lung Cancer Anaemia Survey (SLCAS)

    Clinical and Translational Oncology, Vol. 13, Núm. 5, pp. 328-334

2007

  1. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non-small-cell lung cancer patients: The Spanish Lung Cancer Group trial 9901

    Journal of Clinical Oncology, Vol. 25, Núm. 30, pp. 4736-4742

  2. XPD 312 single nucleotide polymorphism (SNP) predicts survival in stage IIIA-B non-sinall-cell lung cancer (NSCLC) patients (pts) < 59 years (y) treated with chemotherapy followed by surgery

    EJC SUPPLEMENTS